Assesment of the patients with broncopulmonary dysplasia (BPD) in terms of somatic growth, pulmonary problems and neurodevelopmental features on long-term follow-up;Bronkopulmoner displazili hastalarimizin uzun dönem izleminde somatik büyüme, akciǧer sorunlari ve nörogelişimsel özelliklerinin irdelenmesi

Turk Pediatri Arsivi

Volumn 43, Issue 1, 2008, Pages 17-23

  Kavuncuoǧlu, Sultan ^a   Aldemir, Esin Yildiz ^a,b   Altuncu, Emel ^a   Arduç, Ayfer ^a   Alpaslan, Seçil ^a   Arslan, Gülseren ^a   Aksüyek, Ender ^a   Öztüregen, Engin ^a   Çizmeci, Nevzat ^a  

^a MINISTRY OF HEALTH   (Turkey)

^b Saglik Bakanligi Bakirkoy Kadin Dogum ve Cocuk Hastaliklari Egitim ve Arasirma Hastanesi ^*

Author keywords

BPD; Neurodevelopmental follow up; Preterm; Somatic growth

Indexed keywords

ARTICLE; BLINDNESS; BODY GROWTH; CLINICAL ARTICLE; CONTROL GROUP; CONTROLLED STUDY; DISEASE CLASSIFICATION; FOLLOW UP; GESTATIONAL AGE; GROWTH RETARDATION; HOSPITAL; HUMAN; INFORMATION PROCESSING; LONG TERM CARE; LUNG DISEASE; LUNG DYSPLASIA; MICROCEPHALY; NERVE CELL DIFFERENTIATION; NEWBORN; PATIENT ASSESSMENT; PREMATURITY; RESPIRATORY TRACT DISEASE; RESPIRATORY TRACT INFECTION; SCREENING; WEIGHT;

EID: 47249156696     PISSN: 13060015     EISSN: 13086278     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Lee SK, McMillan DD, Ohlson A, et al. Variations in practice and outcomes in the Canadian NICU Network: 1996-1997. Pediatrics 2000; 106:1070-9
2. Lemons JA, Bauer CR, Oh W, et al. Very low birth weight outcomes of the National İnstitutes of Child Health and Human Devolopment Neonatal Research Network, January 1995 through December 1996. Pediatrics 2001; 107(1): E1.
3. Sauve RS, Singhal N. Long-term morbidity of infants with bronchopulmonary dysplasia. Pediatrics 1985; 76: 725-33.
4. Bhutani VK, Abbasi S. Long-term pulmonary consequenses in survivors with bronchopulmonary dysplasia. Clin Perinatol 1992; 19: 649-71.
5. Bregman J, Farrell EE. Neurodevelopmental outcome in infants with bronchopulmonary dysplasia. Clin Perinatol 1992; 19: 673-94.
6. Ballard JL, Khoury JC, Wedig K, Wang L, Eilers-Walsman BL, Lipp R. New Ballard score, expanded to include extremely premature infants. J Pediatr 1991; 119:417-23.
7. Lubchenco LO, Hansman C, Boyd E. Intrauterine growth in length and head circumference as estimated, from live births of gestational ages from 26-42 weeks. Pediatrics 1986; 37: 403-8.
8. Papile L, Burstein J, Burstein R, Koffler H. İncidence and evolution of subependymal and intraventrikular hemorrhage: a study of infants with weights less than 1500 gm. J Pediatr 1978; 92: 529-34.
9. Walsh MC, Kliegman RM. Necrotizing enterocolitis: treatment based on staging criteria. Ped Clin North Am 1986; 33: 179-201.
10. International Committee for Classification of ROP: An international classification of retinopathy of prematurity. II. The Classification of retinal detachment. Arch Ophthalmol 1987;105: 906.
11. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001; 163: 1723-9.
12. Halliday H. Clinical trials of postnatal corticosteroids: inhaled and systemic. Biol Neonate 1999; 76 :29-40.
13. Halliday HL, Ehrenkranz RA. Delayed (>3weeks) postnatal corticosteroids for chronic lung disease in preterm infants (Cochrane Review). Cochrane Database Syst Rev 2001; 2: CD001145.
14. Neyzi O, Binyildiz P, Alp H. Türk çocuklarinda büyüme-gelişme normleri I. Tarti ve boy deǧerleri. İst Tip Fak Mec (Suppl) 1978; 41: 74.
15. Denver. Anlar B, Yalaz K. Denver II Gelişimsel Tarama Testi, Türk çocuklarina uyarlanmasi ve standardizasyonu. HUTF Ped Nöroloji Bilim Dali Ankara 1995; 1-43.
16. Ritchie, SK. Primary care of the premature infant discharges from the intensive care unit. Am J. Maternal/Child Nurs 2002; 27: 76-85.
17. Roth SC, Baudin J, Pezzani-Golds M, Townsend J, Reynolds EO, Steward AL. Relation between neurodevelopmental status very preterm infants at one and eight years. Dev Med Child Neurol 1994; 36: 1049-62.
18. Schmidt B, Asztalos EV, Roberts RS, et al. Trial of İndomethacin prophlaxis in preterm (TIPP) investigators. Impact of bronchopulmonary dysplasia, brain injury and severe retinopathy on outcome of extremely low birth weight infants at 18 months results from the trial of indomethacin prophlaxis in preterms. JAMA 2003; 289: 112.
19. Kerimoǧlu G, Kavuncuoǧlu K, Arslan G, ve ark. Neuromotor developmental follow-up of the preterm infants. SSK Tepecik Eǧitim Hastanesi Dergisi 2004; 14: 33-9.
20. Göçer C, Kavuncuoǧlu S, Akin MA, ve ark. Çok düşük doǧum aǧirlikli riskli pretermlerin nörogelişimsel sorunlari ve nörolojik morbiditeye etki eden faktörlerin araşirilmasi. 14. Ulusal Neonatoloji Kongresi Kongre Kitabi 2006: 179.
21. Yeşinel S, Kavuncuoǧlu S, Yildiz AE, Yildirim YS, Akin MA, Yildiz H. Çok düşük doǧum aǧirlikli riskli prematürelerin somatik gelişmelerine etki eden faktörler. 42. Türk Pediatri Kongresi Kongre Kitabi 2006: 512.
22. Erdem G, Erdoǧan-Bakar E, Yiǧit Ş, Turanli G. Hacettepe Üniversitesi Hastanesi Yenidoǧan Yoǧun Bakim Ünitesinde izlenen prematüre bebeklerin nörogelişimsel İzlemi. Çocuk Saǧliǧi ve Hastaliklari Dergisi 2006; 49: 185-92.
23. Hakulinen AL, Heinonen K, Lansimies E, et al. Pulmonary function and respiratory morbidity in school age children born prematurely and ventilated respiratory insufficiency. Pediatr Pulmonol 1990; 8: 226.
24. Baraldi E, Filippone M, Trevisanutod, et al. Pulmonary function until two years of life infants with bronchopulmonary dysplasia. Am J Respir Crit Care Med 1997; 155: 149.
25. Korhonen P, Koivisto AM, Ikonen S, et al. Very low birth weight bronchopulmonary dysplasia and healty in early childhood. Acta Paediatr 1999; 88: 1385-91
26. Teper RS, Morgan WJ, Cota K, et al. Expiratory flow limitation in infants with bronchopulmonary dysplasia. J Pediatr 1986; 109: 1040-6.
27. Cunningham CK, Mc Millan JA, Gross SJ. Rehospitalization for respiratory illness in infants of less than 32 weeks gestation. Pediatrics 1991; 88: 527-32.
28. Rona RJ, Gulliford MC, Chinn S. Effects of prematurity and intrauterine growth on respiratory health and lung function in childhood. BMJ 1993; 306: 817-20.
29. DeRegnier RO, Gullbert ThW, Mills MM, et al. Growth failure and altered body compozition are established by one month of age in infants with bronchopulmonary dysplasia. J Nutr 1996; 126:168-75.
30. Ehrenkranz SA, Younes N, Lemons JA, et al. Longitudinal growth of hospitalized very low birth weight infants. Pediatrics 1999; 104:280-9.
31. Huysman WA, Ridder M, Bruin NC, et al. Growth and body composition in preterm infants with bronchopulmonary dysplasia. Arch Dis Child Fetal Neonatal Ed 2003; 88: F46-51.
32. Nortway WH, Moss RB, Carlisle KB, et al. Late pulmonary sequelae of bronchopulmonary dysplasia. N Eng J Med 1990; 323: 1793-9.
33. Allen MC, Capute AJ. Neonatal neurodevelopmental examination as a predictor of neuromotor outcome in premature infants. Pediatrics 1989; 83: 498-506.
34. Barrington KJ. The adverse neuro-developmental effects of postnatal steroids in the preterm infants: a systematic review of RCT. BMC Pediatr 2001; 1:1.
35. Yeh TF, Lin JJ, Huang CC, et al. Early dexamethasone therapy in preterm infants: a follow up study. Pediatr 1998; 101: E7.
36. Weiller HA, Paes B, Shah JK, Atkinson SA. Longitudinal assesment of growth and bone mineral accretion in prematurely born infants treated for chronic lung disease with dexamethasone. Early Hum Dev 1997; 47: 271-86.
37. Chiriboga CA, Kuban KC, Durkin M, et al. Factors associated with microcephaly at school age in a very-low-birth weight population. Dev Med Child Neurol 2003; 45: 796-801.
38. Perlman JM. White mater injury in the preterm infant, an important determination of abnormal neurodevelopmental outcome. Early Human Develop. 1998; 53: 99-120.
39. Sholac L, Perlman JM. Hemorragic ischemic cerebral injury in the preterm infant current consept. Clinics in perinatol 2002; 29: 745-63.
40. Henry L, Halliday MD, Chris C, Patterson Chrishanti W.N.L Halahakoon: A Multicenter; Randomized Open study of Early Corticosterid Treatment (OSECT) in preterm infants with respiratory illness: Comparison of early and late treatment and of dexamethasone and inhaled budesonide. Pediatrics 2001: 107: 232-40.
41. Doyle LW, Halliday HL, Ehrenkrans RA, Davis PG, Sinclair JC. İmpact of postnatal systemic corticosteroids on mortality an cerebral palsy in preterm infants: Effect modification by risk for chronic lung disease. Pediatrics 2005; 115: 655-61.
42. Halliday HL, Ehrenkranz RA, Doyle LW. Early postnatal (<96 hours) corticosteroids for prevention of chronic lung disease in preterm infants. Cochrane Database Syst Rev 2003; 1: CD001146.
43. Halliday HL, Ehrenkranz RA, Doyle LW. Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants. Cochrane Database Syst Rev 2003; 1: CD001145.
44. Wilson TT, Waters l, Patterson CC, et al. Neurodevelopmental and respiratory follow-up resulst at 7 years for children from the United Kingdom and Ireland enrolled in a randomized trial early and late postnatal corticosteroid treatment, systemic and inhaled (the open study of early corticosteroid treatment). Pediatrics 2006 ;117: 2196-205.
45. Flynn T, Bancalari E, Synder ES, et al. A cohort study of transcutaneous oxygen tension and incidence and severity of retinopathy of prematurity. N Eng J Med 1992; 326: 1050-4.
46. Satar M, Narli N, Soylu M, Özcan A. Prematüre retinopatisi ve risk faktörleri. Çukurova Üniversitesi Tip Fakültesi Dergisi 1998; 23: 29-34. 24-28